Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.32 | -0.08 | 0.06 | 0.01 |
| FCF Yield | -80.61% | -73.36% | -16.68% | -104.64% |
| EV / EBITDA | -0.92 | -1.26 | -4.77 | -0.66 |
| Quality | ||||
| ROIC | -159.65% | -70.87% | -36.44% | -84.25% |
| Gross Margin | -53.38% | -53.41% | -34.79% | -62.71% |
| Cash Conversion Ratio | 0.81 | 0.78 | 0.65 | 0.79 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.38% | 30.69% | -1.18% | -49.12% |
| Free Cash Flow Growth | -6.60% | -43.28% | 9.96% | 36.85% |
| Safety | ||||
| Net Debt / EBITDA | 0.15 | 0.01 | 0.25 | 0.29 |
| Interest Coverage | 0.00 | -184.58 | -174.65 | -3,178.37 |
| Efficiency | ||||
| Inventory Turnover | 1.83 | 1.31 | 1.29 | 0.51 |
| Cash Conversion Cycle | 233.27 | 281.90 | 203.80 | 698.29 |